Want to see HK:8307 full AI Analyst Report?
8307 Stock Chart & Stats
HK$0.17
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.17
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.02 - HK$0.24
Previous CloseN/A
Volume16.00K
Average Volume (3M)24.27K
Market Cap
HK$48.80M
Enterprise ValueHK$42.34M
Total Cash (Recent Filing)HK$29.46M
Total Debt (Recent Filing)HK$17.57M
Price to Earnings (P/E)1180.0
Beta0.28
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding396,736,000
10 Day Avg. Volume55,600
30 Day Avg. Volume24,266
Financial Highlights & Ratios
PEG Ratio-0.49
Price to Book (P/B)11.39
Price to Sales (P/S)1.24
P/FCF Ratio13.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Positive Cash GenerationThe company has produced positive operating and free cash flow each year shown, which is a durable strength. Predictable cash generation funds operations and small capex needs, reduces immediate refinancing pressure and provides a buffer to support working capital and strategic actions over coming months.
Stable EBITDA Margins (mid-teens)Mid‑teen EBITDA margins across multiple years indicate resilient core operating profitability despite top-line swings. Consistent underlying margins can sustain cash generation and provide operational leverage if revenue stabilizes, supporting medium‑term earnings durability and internal funding capacity.
Return To Net Profitability In FY2026A return to positive net income and a small net margin improvement signals operational recovery and management execution. Restoring profitability reduces reliance on external capital, helps rebuild equity over time and gives management more flexibility for reinvestment or deleveraging in the medium term.
Bears Say
Elevated And Rising LeverageLeverage increased materially versus the company’s recent history, leaving a thin equity cushion. High debt relative to equity raises refinancing and interest risk, reduces financial flexibility, and can limit the firm's ability to absorb downside or fund growth without costly financing.
Revenue Volatility And Recent DeclineSharply variable top-line trends and a recent double‑year decline hinder predictability of cash flows and investment planning. Persistent revenue weakness pressures margins, makes forecasting and customer retention harder, and raises execution risk for strategies that rely on stable demand.
Material Drop In Free Cash Flow And Uneven Cash ConversionA severe year‑over‑year fall in free cash flow and inconsistent cash conversion reduce the company’s cushion to service debt or fund growth. Even with positive FCF historically, a large drop heightens vulnerability to operational setbacks and constrains options for deleveraging or strategic investment.
8307 FAQ
What was Medicskin Holdings Ltd.’s price range in the past 12 months?
Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.
What is Medicskin Holdings Ltd.’s market cap?
Medicskin Holdings Ltd.’s market cap is HK$48.80M.
When is Medicskin Holdings Ltd.’s upcoming earnings report date?
Medicskin Holdings Ltd.’s upcoming earnings report date is Nov 16, 2026 which is in 101 days.
How were Medicskin Holdings Ltd.’s earnings last quarter?
Medicskin Holdings Ltd. released its earnings results on Jun 22, 2026. The company reported HK$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.002.
Is Medicskin Holdings Ltd. overvalued?
According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued.
Does Medicskin Holdings Ltd. pay dividends?
Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here
What is Medicskin Holdings Ltd.’s EPS estimate?
Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medicskin Holdings Ltd. have?
Medicskin Holdings Ltd. has 396,736,000 shares outstanding.
What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?
Medicskin Holdings Ltd. reported an EPS of HK$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 22.549%.
Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:8307
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medicskin Holdings Ltd.
Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through inter alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. It provides medical consultancy services. In addition, the company engages in the sale of skincare products and medical skincare services. Further, it provides prevention healthcare services; body care and men care services, as well as offer mediskin vaccination. Medicskin Holdings Limited was founded in 2000 and is headquartered in Sheung Wan, Hong Kong. The company is a subsidiary of Topline Worldwide Limited.
Technical Analysis
EuroEyes International Eye Clinic Limited
―
Raily Aesthetic Medicine International Holdings Limited
―
Beauty Farm Medical & Health Industry, Inc.
―
Arrail Group Ltd.
―
Saint Bella Inc.
―